# A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight

> **NCT06230523** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 263 (actual)

## Conditions studied

- Obesity
- Overweight and Obesity

## Interventions

- **DRUG:** LY3841136
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06230523
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-05
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-08-14
- **Target enrollment:** 263 (ACTUAL)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06230523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06230523, "A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06230523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*